DoD Tuberous Sclerosis Complex, Clinical Translational Research Award
ID: 353646Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353646
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a funding opportunity for the Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award. This grant aims to support innovative studies that advance the understanding, prevention, and treatment of Tuberous Sclerosis Complex (TSC), focusing on areas such as neuropsychiatric disorders, tumors, epilepsy, and maternal-fetal health. With an estimated total program funding of $3.4 million, the program anticipates awarding two grants, with individual budgets capped at $1 million and $1.15 million for collaborative projects. Key deadlines include a pre-application submission by June 12, 2024, and a full application due by August 1, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524TSCRPCTRA__GG.pdf
    The Department of Defense (DOD) announces its FY24 funding opportunity for the Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award. This initiative seeks applications for studies that advance understanding, prevention, and treatment of Tuberous Sclerosis Complex (TSC) with a focus on various areas including neuropsychiatric disorders, tumors associated with TSC, epilepsy, and maternal-fetal health. A total of $8 million is allocated for this funding opportunity, which aims to support research relevant to military service members, veterans, and the American public. Key deadlines include the pre-application submission by June 12, 2024, and the full application by August 1, 2024. Eligible applicants include independent researchers and organizations from both intramural and extramural settings. The awards will be made with a budget cap of $1 million for individual submissions and $1.15 million for those employing a Partnering PI option, which encourages collaboration between clinicians and research scientists. The two-tier review process involves peer evaluation based on clinical translational potential, impact, and research strategy, followed by programmatic assessment. Overall, this funding opportunity emphasizes the importance of innovative research to improve diagnostics and treatment related to TSC while adhering to stringent application guidelines.
    Similar Opportunities
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Combat Readiness - Medical Translational Research Award (CRRP TRA) to support high-impact translational research aimed at enhancing medical readiness for military personnel. This funding opportunity seeks proposals that address critical areas such as battlefield diagnostics, treatments for life-threatening injuries, and operational health threats, with an emphasis on projects that leverage existing resources and demonstrate clear relevance to military health. The total estimated funding for this initiative is approximately $3.3 million, with the expectation of awarding around three grants, and key deadlines include pre-applications due by September 4, 2024, and full proposals by December 5, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Traumatic Brain Injury and Psychological Health, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Traumatic Brain Injury and Psychological Health Translational Research Award (TRA) to advance research aimed at improving care for psychological health conditions and traumatic brain injuries (TBI). This grant opportunity focuses on hypothesis-driven research that seeks to develop novel healthcare products, clinical practices, and technologies, with an emphasis on translational research that leads to practical applications in clinical settings. With an estimated total program funding of $17.05 million, the program anticipates awarding approximately 14 grants, with funding caps of $500,000 for smaller projects and $1 million for larger, more complex research initiatives. Interested applicants must submit a pre-application by June 27, 2024, and full applications by October 3, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org.
    DoD Arthritis Research, Clinical Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Arthritis Research Clinical Research Award (ATRP CRA) to support clinical research aimed at improving the understanding and management of various forms of arthritis, particularly in military personnel and their families. This grant program encourages innovative research proposals that address disease-specific factors and interventions, with a focus on enhancing patient outcomes and informing clinical care or policy. With an estimated total funding of $6 million, the program anticipates awarding approximately three grants, including one for a clinical trial, with applications due by October 30, 2024, and a pre-application deadline of October 16, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    CDMRP Neurofibromatosis Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Neurofibromatosis Clinical Trial Award to support innovative clinical trials aimed at addressing high-impact issues related to neurofibromatosis (NF), including NF1, NF2, and schwannomatosis. Applicants are required to present a clear clinical trial design, preliminary data, and access to suitable patient populations, with a focus on enhancing understanding, diagnosis, and treatment of NF to benefit service members, veterans, and the public. This funding opportunity, totaling approximately $1.6 million for the award, encourages collaborative proposals involving academia, industry, and military branches, with key deadlines for pre-applications on September 12, 2024, and full applications by October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Multiple Sclerosis, Exploration - Hypothesis Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the FY24 Multiple Sclerosis Exploration - Hypothesis Development Award (MSRP EHDA), aimed at fostering innovative research in the field of multiple sclerosis (MS). This grant program supports high-risk, high-gain research concepts that challenge existing paradigms and lay the groundwork for future scientific investigations, with a focus on areas such as central nervous system repair and mechanisms contributing to MS etiology. The total estimated funding for this program is approximately $2 million, with an expected eight awards, and applications must follow a two-step submission process, including a pre-application due by June 10, 2024, and a full application due by October 7, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Kidney Cancer, Translational Research Partnership Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Kidney Cancer Translational Research Partnership Award, a federal grant aimed at fostering collaborative research partnerships between clinicians and research scientists to advance kidney cancer treatment and care. This opportunity encourages the development of translational research projects that address significant problems in kidney cancer, requiring partnerships that include one clinician and one research scientist who contribute equally to the research design and execution. With an estimated total program funding of $7.68 million, the program anticipates awarding approximately six grants, each with a maximum budget of $800,000 over a three-year period. Interested applicants must submit a pre-application letter of intent by September 24, 2024, followed by a full application due by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Traumatic Brain Injury and Psychological Health, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Traumatic Brain Injury and Psychological Health Clinical Trial Award (CTA) to support clinical trials aimed at improving the understanding, prevention, and treatment of traumatic brain injuries (TBI) and psychological health conditions affecting military personnel and veterans. This funding opportunity encourages innovative research methodologies, including Community-Based Participatory Research (CBPR), and requires applicants to demonstrate robust statistical analyses, participant recruitment strategies, and regulatory compliance. With an estimated total program funding of $58.9 million, the CTA anticipates awarding approximately 18 grants across various research levels, with budget caps ranging from $500,000 to $4 million, and key deadlines include a pre-application by June 27, 2024, and a full application by October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Tick-Borne Disease Therapeutic/Diagnostic Research Award to support innovative research aimed at addressing tick-borne diseases, particularly Lyme disease. This grant seeks applications focused on therapeutic and diagnostic development with demonstrated feasibility, emphasizing projects that can improve patient care and quality of life for military Service Members, Veterans, and the general public. With an estimated total program funding of $2,656,000 and the expectation of awarding two grants, applicants must submit a pre-application through eBRAP by October 3, 2024, followed by a full application via Grants.gov upon invitation. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    Toxic Exposures Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Toxic Exposures Translational Research Award (TRA) to support research on adverse health outcomes related to military toxic exposures. This grant aims to facilitate translational research that bridges basic science and clinical applications, focusing on developing diagnostics, treatment strategies, and understanding exposure mechanisms to improve health care for service members and their families. With an estimated total program funding of $12.8 million and the expectation of awarding six grants, applicants must submit a pre-application by August 13, 2024, followed by a full application due by November 7, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    CDMRP Neurofibromatosis Investigator-Initiated Research Program
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Neurofibromatosis Investigator-Initiated Research Program (NFRP) grant to support innovative research projects focused on neurofibromatosis (NF). This program aims to enhance understanding, diagnosis, and treatment of NF1, NF2, and schwannomatosis, with a particular emphasis on improving the quality of life for affected individuals, including military personnel and veterans. The total estimated funding for this initiative is $5.36 million, with up to six awards anticipated, and applications must be submitted by October 3, 2024, following a pre-application deadline of September 12, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.